CRP and rheumatoid arthritis: The levels of C-reactive protein (CRP), which is a marker of RA activity, have been shown to be higher in HTLV-1-positive patients with RA before receiving treatment with biologic DMARDs than the levels of CRP HTLV-1-negative patients [67].